Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors

Ovarian cancer is the fifth leading cause of cancer deaths. Chemoresistance, particularly against platinum compounds, contributes to a poor prognosis. Histone deacetylase inhibitors (HDACi) and heat shock protein 90 inhibitors (HSP90i) are known to modulate pathways involved in chemoresistance. This...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Int J Mol Sci
Huvudupphovsmän: Rodrigues Moita, Ana J., Bandolik, Jan J., Hansen, Finn K., Kurz, Thomas, Hamacher, Alexandra, Kassack, Matthias U.
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7663919/
https://ncbi.nlm.nih.gov/pubmed/33167494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21218300
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk